Align technology announces second quarter 2023 financial results

Tempe, ariz.--(business wire)--align technology, inc. (nasdaq: algn), a leading global medical device company that designs, manufactures, and sells the invisalign® system of clear aligners, itero™ intraoral scanners, and exocad™ cad/cam software for digital orthodontics and restorative dentistry, today reported financial results for the second quarter ("q2'23"). q2'23 total revenues were $1,002.2 million, up 6.3% sequentially and up 3.4% year-over-year. q2'23 clear aligner revenues were $832.7.
ALGN Ratings Summary
ALGN Quant Ranking